Wilbanks Smith & Thomas Asset Management LLC Sells 800 Shares of Varex Imaging Co. (NASDAQ:VREX)

Wilbanks Smith & Thomas Asset Management LLC trimmed its position in Varex Imaging Co. (NASDAQ:VREX) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,600 shares of the company’s stock after selling 800 shares during the period. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Varex Imaging were worth $238,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. SG Americas Securities LLC purchased a new position in shares of Varex Imaging during the 3rd quarter worth $498,000. Mackenzie Financial Corp bought a new position in Varex Imaging in the 3rd quarter worth $230,000. Allspring Global Investments Holdings LLC lifted its position in Varex Imaging by 3.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,018,300 shares of the company’s stock valued at $56,714,000 after purchasing an additional 88,406 shares in the last quarter. Knights of Columbus Asset Advisors LLC grew its holdings in Varex Imaging by 0.5% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 170,232 shares of the company’s stock valued at $3,199,000 after purchasing an additional 788 shares during the period. Finally, Versor Investments LP purchased a new stake in Varex Imaging in the third quarter worth about $270,000.

Varex Imaging Stock Down 5.1 %

VREX opened at $15.59 on Friday. Varex Imaging Co. has a fifty-two week low of $14.56 and a fifty-two week high of $23.90. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.37 and a current ratio of 4.30. The stock has a market cap of $632.95 million, a price-to-earnings ratio of 16.24, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72. The firm’s fifty day moving average is $17.32 and its 200 day moving average is $18.49.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.16 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.07). Varex Imaging had a net margin of 4.90% and a return on equity of 8.34%. The business had revenue of $206.20 million during the quarter, compared to analysts’ expectations of $205.15 million. During the same quarter in the previous year, the firm earned $0.26 earnings per share. Varex Imaging’s revenue was down 9.6% on a year-over-year basis. On average, sell-side analysts forecast that Varex Imaging Co. will post 0.99 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, TheStreet downgraded Varex Imaging from a “b-” rating to a “c” rating in a research note on Tuesday, February 6th.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.